Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001213900-25-005025
Filing Date
2025-01-21
Accepted
2025-01-21 16:25:33
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5323
  Complete submission text file 0001213900-25-005025.txt   7011
Mailing Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021
Business Address 8181 ARISTA PLACE STE 100 BROOMFIELD CO 80021 833 275 2266
Aclarion, Inc. (Subject) CIK: 0001635077 (see all company filings)

EIN.: 473324725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93897 | Film No.: 25542777
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)

Mailing Address 135 SYCAMORE DRIVE ROSLYN NY 11576
Business Address 135 SYCAMORE DRIVE ROSLYN NY 11576 (516) 521-1354
SEG Opportunity Fund, LLC (Filed by) CIK: 0002041952 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G